NO881501L - RECOMBINANT HTLV-111 PROTEINS AND USES OF THESE. - Google Patents

RECOMBINANT HTLV-111 PROTEINS AND USES OF THESE.

Info

Publication number
NO881501L
NO881501L NO88881501A NO881501A NO881501L NO 881501 L NO881501 L NO 881501L NO 88881501 A NO88881501 A NO 88881501A NO 881501 A NO881501 A NO 881501A NO 881501 L NO881501 L NO 881501L
Authority
NO
Norway
Prior art keywords
proteins
protein
htlv
fusion protein
fusion
Prior art date
Application number
NO88881501A
Other languages
Norwegian (no)
Other versions
NO881501D0 (en
Inventor
Debra Lynn
Kashayar Javaberian
William Thomas Mueller
John Farley
Original Assignee
Repligen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repligen Corp filed Critical Repligen Corp
Publication of NO881501D0 publication Critical patent/NO881501D0/en
Publication of NO881501L publication Critical patent/NO881501L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Nye, rekoobinante HTLV-III-sammensmeltningsproteiner benevnt RIO, PB1, 590, KH1, og HIV-delen av hvert av disse proteiner er anvendelige i diagnosen, profylaksen eller terapien av AIDS. Protein RIO er et 95 kO sammensmeltningsprotein; protein1 er et 26 IcO sammensmeltningsprotein; protein 590 er et 86 kD sammensmelt-ningsproteini og protein KH1 er et 70 kO saimnensmeltningsprotein. Disse proteiner betraktes å være spesielt anvendelige for å fremstille vaksiner mot HTLV-III-viruset.Novel, recoobinant HTLV-III fusion proteins called RIO, PB1, 590, KH1, and the HIV portion of each of these proteins are useful in the diagnosis, prophylaxis, or therapy of AIDS. Protein RIO is a 95 kO fusion protein; protein1 is a 26 IcO fusion protein; protein 590 is an 86 kD fusion protein and protein KH1 is a 70 kO fusion protein. These proteins are considered to be particularly useful in the production of vaccines against the HTLV-III virus.

NO88881501A 1987-10-09 1988-04-07 RECOMBINANT HTLV-111 PROTEINS AND USES OF THESE. NO881501L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10723187A 1987-10-09 1987-10-09

Publications (2)

Publication Number Publication Date
NO881501D0 NO881501D0 (en) 1988-04-07
NO881501L true NO881501L (en) 1989-04-10

Family

ID=22315557

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88881501A NO881501L (en) 1987-10-09 1988-04-07 RECOMBINANT HTLV-111 PROTEINS AND USES OF THESE.

Country Status (6)

Country Link
JP (1) JPH01193228A (en)
KR (1) KR890006250A (en)
AU (1) AU613944B2 (en)
NO (1) NO881501L (en)
PT (1) PT87208A (en)
ZA (1) ZA883261B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ215867A (en) * 1985-04-19 1989-10-27 Hoffmann La Roche Aids envelope protein, dna vectors and method of production
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
EP0525828A3 (en) * 1986-08-01 1993-02-24 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus

Also Published As

Publication number Publication date
PT87208A (en) 1989-07-31
KR890006250A (en) 1989-06-12
JPH01193228A (en) 1989-08-03
NO881501D0 (en) 1988-04-07
AU2117288A (en) 1989-04-13
AU613944B2 (en) 1991-08-15
ZA883261B (en) 1988-12-06

Similar Documents

Publication Publication Date Title
ATE294864T1 (en) OUTER MEMBRANE PROTEIN OF HAEMOPHILUS
ATE91714T1 (en) TRANSFORMATION OF TRICHODERMA.
FI873141A0 (en) DAEGGDJURS INTERLEUKIN-4.
BR9500732B8 (en) DIAGNOSTIC KIT FOR DETECTION OF ANTIBODIES THAT CAUSE IMMUNODEFICIENCY.
DE3382837T2 (en) Production of functional human urokinase proteins
ES2108681T3 (en) EXPRESSION OF HUMAN SERUM ALBUMIN IN METHYLTROPHIC YEAST.
EP0306219A3 (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
EP0255190A3 (en) Recombinant polypeptides and their uses, inclusing assay for aids virus
BG44537A3 (en) Method for preparing of 2- amino- 3- ethoxycarbonylamino- 6- (p- fluor- benzylamino)- piridine gluconate
DK573587D0 (en) PROCEDURE FOR PREPARING A FACTOR VIII (AHF) CONTAINING FRACTION
DE58908428D1 (en) Secretary mutant of Escherichia coli.
NO881501L (en) RECOMBINANT HTLV-111 PROTEINS AND USES OF THESE.
ATE123523T1 (en) EXPRESSION OF HIV1 AND 2 POLYPEPTIDES AND THEIR USE.
PT87207A (en) PROCESS FOR PREPARING RECOMBINANT HTLV-III PROTEINS AND USES THEREOF
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
ES2101694T3 (en) EXPRESSION OF PROTEINIC SWEETENERS IN YEAST.
WO1989009227A3 (en) Pf10 to pf19 peptides of an hiv retrovirus, process for synthetizing said peptides and their use, in particular for diagnosis
DK708488D0 (en) FACTOR IN PREPARATION
FI881123A0 (en) INACTIVATION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) MEDICINES IN PHENOL AND PROTEIN INHALATION.
ES2059323T3 (en) PROCEDURE FOR THE PRODUCTION OF A PASTEURIZED IMMUNOGLOBULIN PREPARATION.
ATE110112T1 (en) METHODS AND SYSTEMS FOR THE PRODUCTION OF HIV ANTIGENS.
FR2325329A2 (en) Sialic acids and glycoproteins from lactoserum from cheese making - with improved spen. and higher yield
EP0305777A3 (en) Synthesis of human immunodeficiency virus type 1 antigens and their use as diagnostic and therapeutic agents
PT592574E (en) PROCESS OF PRODUCTION OF RECOMBINANT PROTEINS AND HOSPITAL CELLS USED
EP0339569A3 (en) Expression of the hiv 24 kda gag protein in methylotrophic yeasts